Brief: Nls Pharmaceutics AG - Announces Final Results From A Preclinical Study For Nls-4 (Lauflumide)

NewcelX AG

30/11/2021 13:45

Nov 30 (Reuters) - NLS Pharmaceutics AG  NLSP.O :
    * NLS PHARMACEUTICS AG - ANNOUNCES FINAL RESULTS FROM A
PRECLINICAL STUDY FOR NLS-4 (LAUFLUMIDE)
    * NLS PHARMACEUTICS - BELIEVES NLS-4 OFFERS PROMISE TO
BECOME
FOUNDATIONAL TREATMENT FOR CHRONIC FATIGUE ASSOCIATED WITH
SYMPTOMS OF LONG-COVID
    * NLS PHARMACEUTICS AG - BELIEVES NLS-4 SHOULD IMPROVE
RECOVERY
FROM CFS IN HUMANS AT A DOSE THAT IS FOUR TIMES LOWER THAN THAT
USED FOR MODAFINIL

Source text for Eikon:  ID: 
Further company coverage:  NLSP.O 

 ((Reuters.Briefs@thomsonreuters.com;))